title: APRIL, BCMA and TACI proteins are abnormally expressed in non-small cell lung cancer.
abstract: Lung cancer is the leading cause of cancer-associated mortality. Non-small cell lung cancer (NSCLC) accounts for >80% of lung cancers. The overall survival for NSCLC is dismal, with a 5-year survival of <5% for patients. Thus, identifying an effective biomarker for early diagnosis of lung cancer is the first essential step to reduce mortality. It has been recognized that certain inflammatory and immune responses are important in lung cancer development and prevention. The present study demonstrated that, in NSCLC, a proliferation-inducing ligand (APRIL), B-cell maturation antigen (BCMA)and transmembrane activator and CAML interactor (TACI) proteins are abnormally expressed by immunohistochemistry, reverse transcription-quantitative polymerase chain reaction and western blotting. In addition, the expression of APRIL, BCMA and TACI were observed to be involved in extracellular signal-regulated kinase (ERK)1/2 activation in A549 cells. Overall, the present study provides evidence that APRIL and its receptors, BCMA and TACI, may play roles in the biological processes of NSCLC tumors through the ERK1/2 signaling pathway.
authors.affiliation: Department of Neurosurgery, The Fourth Hospital of Jinan, Jinan, Shandong 250031, P.R. China.
authors.forename: Hengli
authors.initials: H
authors.lastname: Dou
authors.affiliation: Department of Neurosurgery, The Fourth Hospital of Jinan, Jinan, Shandong 250031, P.R. China.
authors.forename: Zhaohua
authors.initials: Z
authors.lastname: Yan
authors.affiliation: Department of Neurosurgery, The Fourth Hospital of Jinan, Jinan, Shandong 250031, P.R. China.
authors.forename: Meng
authors.initials: M
authors.lastname: Zhang
authors.affiliation: Department of Neurosurgery, The Fourth Hospital of Jinan, Jinan, Shandong 250031, P.R. China.
authors.forename: Xiaoxin
authors.initials: X
authors.lastname: Xu
keywords: APRIL; BCMA; ERK1/2; TACI; lung cancer